2型糖尿病成人中体重变化与心血管疾病事件及死亡率之间的关联:观察性研究与行为干预试验的系统综述
该系统综述纳入14项观察性研究和3项行为干预试验,探讨2型糖尿病成人中体重变化与心血管疾病事件及死亡率的关系。观察性研究显示体重增加(相比体重不变)与心血管疾病事件及全因死亡率风险升高相关,非刻意减重与全因死亡率升高相关,而刻意减重的关联不明确。针对减重的行为干预对心血管疾病事件无影响(合并HR 0.95,95%CI 0.71–1.27;I²=50.1%)。
要点
- 体重增加(相比体重不变)与2型糖尿病成人心血管疾病事件及全因死亡率风险升高相关。
- 非刻意减重(相比体重不变)与全因死亡率升高相关,刻意减重的关联不明确。
- 针对减重的行为干预对心血管疾病事件无影响(合并HR 0.95,95%CI 0.71–1.27;I²=50.1%)。
核心结论
- 体重增加与2型糖尿病成人心血管疾病及死亡率风险升高相关,但缺乏数据支持行为减重干预用于该人群的心血管疾病预防。
- 需要对行为干预研究进行长期随访,以了解其对心血管疾病和死亡率的影响,并为体重管理建议和支持政策提供依据。
研究设计与样本
- 系统综述,检索MEDLINE、EMBASE、Web of Science、CINAHL和Cochrane Library(CENTRAL)至2019年7月9日。
- 从13227篇文章中纳入17项研究(14项观察性研究、3项试验),纳入标准为报告2型糖尿病成人中体重变化与心血管疾病和/或死亡率结局。
- 对观察性研究进行叙述性综合,对试验数据进行Meta分析。
主要发现
- 体重增加(相比体重不变)与心血管疾病事件风险升高相关(HR范围1.13 [1.00, 1.29]至1.63 [1.11, 2.39])。
- 体重增加(相比体重不变)与全因死亡率风险升高相关(HR范围1.26 [1.12, 1.41]至1.57 [1.33, 1.85])。
- 非刻意减重(相比体重不变)与全因死亡率风险升高相关。
- 刻意减重(相比体重不变)与全因死亡率的关联不明确。
- 针对减重的行为干预对心血管疾病事件无影响(合并HR 0.95 [95%CI 0.71, 1.27];I²=50.1%)。
关键数值与推荐
- 体重增加(相比体重不变)与心血管疾病事件风险升高相关(HR范围1.13 [1.00, 1.29]至1.63 [1.11, 2.39])。
- 体重增加(相比体重不变)与全因死亡率风险升高相关(HR范围1.26 [1.12, 1.41]至1.57 [1.33, 1.85])。
- 针对减重的行为干预对心血管疾病事件无影响(合并HR 0.95 [95%CI 0.71, 1.27];I²=50.1%)。
临床怎么用
- 原文未据此给出推荐;原文结论指出体重增加与心血管疾病及死亡率风险升高相关,但缺乏数据支持行为减重干预用于2型糖尿病成人的心血管疾病预防。
- 原文指出需要对行为干预研究进行长期随访,以了解其对心血管疾病和死亡率的影响,并为体重管理建议和支持政策提供依据。
局限性
- 大多数研究存在中等偏倚风险,三项研究存在高偏倚风险,原因是潜在的未控制混杂和体重评估方法。
- 原文结论指出需要对行为干预研究进行长期随访,以了解其对心血管疾病和死亡率的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Weight loss is often recommended in the treatment of type 2 diabetes. While evidence has shown that large weight loss may lead to diabetes remission and improvement in cardiovascular risk factors, long-term impacts are unclear. We performed a systematic review of studies of weight loss and other weight changes and incidence of CVD among people with type 2 diabetes. METHODS: Observational studies of behavioural (non-surgical and non-pharmaceutical) weight changes and CVD events among adults with type 2 diabetes, and trials of behavioural interventions targeting weight loss, were identified through searches of MEDLINE, EMBASE, Web of Science, CINAHL, and The Cochrane Library (CENTRAL) until 9 July 2019. Included studies reported change in weight and CVD and/or mortality outcomes among adults with type 2 diabetes. We performed a narrative synthesis of observational studies and meta-analysis of trial data. RESULTS: Of 13,227 identified articles, 17 (14 observational studies, three trials) met inclusion criteria. Weight gain (vs no change) was associated with higher hazard of CVD events (HRs [95% CIs] ranged from 1.13 [1.00, 1.29] to 1.63 [1.11, 2.39]) and all-cause mortality (HRs [95% CIs] ranged from 1.26 [1.12, 1.41] to 1.57 [1.33, 1.85]). Unintentional weight loss (vs no change) was associated with higher risks of all-cause mortality, but associations with intentional weight loss were unclear. Behavioural interventions targeting weight loss showed no effect on CVD events (pooled HR [95% CI] 0.95 [0.71, 1.27]; I2 = 50.1%). Risk of bias was moderate in most studies and was high in three studies, due to potential uncontrolled confounding and method of weight assessment. CONCLUSIONS/INTERPRETATION: Weight gain is associated with increased risks of CVD and mortality, although there is a lack of data supporting behavioural weight-loss interventions for CVD prevention among adults with type 2 diabetes. Long-term follow-up of behavioural intervention studies is needed to understand effects on CVD and mortality and to inform policy concerning weight management advice and support for people with diabetes. PROSPERO registration CRD42019127304.
引用
- Strelitz J, Lawlor ER, Wu Y, et al. Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervention trials. Diabetologia. 2021. PMID: 34859263. doi:10.1007/s00125-021-05605-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。